| GDDY |
Report |
Total revenue |
IN-LINE |
pred ~$1.301B vs. cons $1.294B |
MEDIUM |
| GDDY |
Report |
Total bookings |
IN-LINE |
pred ~$1.431B vs. cons $1.425B |
LOW |
| GDDY |
Report |
Normalized EBITDA |
IN-LINE |
pred ~$432M vs. cons $428M |
MEDIUM |
| GDDY |
Guide |
3Q26 total-revenue guidance |
LOWER |
guide ~$1.305B vs. cons $1.318B (3Q26) |
MEDIUM |
| GDDY |
Guide |
FY26 total-revenue guidance midpoint |
LOWER |
guide ~$5.235B vs. cons $5.280B (FY26) |
MEDIUM |
| GDDY |
Guide |
FY26 free-cash-flow guidance |
LOWER |
guide ~$1.800B vs. cons $1.820B (FY26) |
MEDIUM |
| GDDY |
Guide |
FY26 normalized EBITDA margin |
UNCHANGED |
guide ~33.1% vs. cons 33.1% (FY26) |
MEDIUM |
| GDDY |
Return |
Day-1 residual (stock − beta × S&P 500) |
-4.0% |
— |
MEDIUM |
| GDDY |
Return |
5-day cumulative residual |
-5.5% (FOLLOW-THROUGH) |
A modest ~$1.301B revenue result versus ~$1.294B consensus and ~$432M EBITDA versus ~$428M consensus is unlikely to offset a ~ $1.305B 3Q26 revenue guide versus ~$1.318B consensus; unchanged ~$5.235B FY26 revenue and ~$1.800B FCF targets imply out-period estimate cuts. |
MEDIUM |